TEHRAN – Iranian and Chinese officers have mentioned methods to foster collaboration in the health sector, significantly supplying prescribed drugs, uncooked supplies, and medical tools.
The officers met on the sidelines of the sixteenth BRICS Health Ministerial Meeting, held in Chandigarh, India, from July 21 to 25.
Highlighting the significance of conventional medication in the 2 nations, Ali Jafarian, a senior advisor to the health minister, expounded on the mixing of Persian medication into the nationwide health system, utilizing an evidence-based medical method to guarantee acceptable and secure utilization of conventional medication, and known as for the growth of ties in this sector, IRNA reported.
Referring to analysis cooperation in vaccine manufacturing inside the BRICS framework, Jafarian highlighted the 2 nations’ potential for the joint growth of vaccines. The official additionally underscored the significance of sharing data, experience, and expertise between Iran and China.
For his half, China’s deputy director for the National Health Commission, Zeng Yixin, welcomed the growth of bilateral ties in line with the present memoranda of understanding between Beijing and Tehran. The official introduced willingness to deepen collaboration in conventional medication, noting that conventional medication has particular significance to China; it isn’t merely a key part of the healthcare system, however a vital a part of the cultural heritage of the nation.
In 2025, Iran and China agreed to implement joint applications in the pharmaceutical and medical fields below the 25-year settlement signed by the 2 nations, IRNA quoted Hamid Inanlou, an official with the Food and Drug Administration (FDA), as saying.
The joint applications intention to enhance industrial, scientific, and industrial capacities of the 2 nations, improve home manufacturing, and facilitate entry to regional markets, he mentioned.
Part of the 25-year strategic partnership focuses on increasing collaborations in the health sector, together with sharing experience and expertise, conducting medical analysis, coaching, exchanging specialised human sources, and growing new medicines, he added.
Manufacturing medical and laboratory tools resembling syringes, diagnostic kits, health merchandise, joint funding, and the institution of joint firms, Inanlou additional famous.
In June 2025, Ding Zhisheng, the Vice Premier of the People’s Republic of China, expressed China’s willingness to improve scientific and technological cooperation with Iran below the Belt and Road Initiative (BRI).
Zhisheng met Hossein Afshin, the Vice President for Science, Technology, and Knowledge-Based Economy, on the sidelines of the 2nd Belt and Road Conference on Science and Technology Exchange held in Chengdu, the capital of southwest China’s Sichuan Province, from June 10 to 12.
Referring to the achieved agreements between the 2 nations, the Chinese official mentioned China is keen to successfully implement the Iran-China strategic partnership and promote high-quality cooperation inside the framework of the BRI. “We seek to develop the capacity for cooperation in science and technology between the two sides to bring more tangible benefits to the people of both countries,” IRNA quoted Zhisheng as saying.
Active health diplomacy at BRICS ministerial assembly
Attending the sixteenth BRICS Health Ministerial Meeting, the Iranian delegation actively participated in drafting a declaration and placing ahead technical and authorized proposals to strengthen health cooperation amongst BRICS member states.
Iran’s place basically prioritized the pursuit of consensus whereas safeguarding nationwide pursuits, preserving the authority of regulatory our bodies, increasing manufacturing and analysis capacities, making certain equitable entry to medicines, vaccines, and health applied sciences, and fostering cooperation in conventional medication and psychological health, IRNA reported.
The Iranian delegation emphasised that BRICS cooperation should advance past declarations and turn into joint, actionable initiatives yielding measurable outcomes; in addition they underscored that entry to health merchandise and applied sciences shouldn’t be hindered by obstacles that disrupt provide chains, expertise switch, joint manufacturing, or sufferers’ well timed entry to care.
Elaborating on the health achievements of the nation throughout crises, Jafarian put ahead three key priorities for the event of the ‘BRICS Action Plan’.
The first proposal highlighted strengthening joint preparedness, which incorporates growing early warning techniques, emergency response networks, combating antimicrobial resistance and environmental threats, whereas respecting nationwide sovereignty.
Developing pharmaceutical improvements was the second proposal, entailing a shift from one-way expertise switch towards collaborative analysis, native manufacturing, and resilient provide chains.
The third suggestion centered on enhancing regulatory cooperation. Announcing Iran’s readiness to take part in BRICS GxP initiatives, the official highlighted the significance of sharing experiences and decreasing duplication of efforts to speed up entry to secure, high-quality medicines.
He went on to say that regardless of intense pressures brought on by the current unlawful US-Israeli assaults towards the nation, significantly hospitals, health employees, and the pharmaceutical provide chain, the supply of important health providers in Iran by no means got here to a halt, defining the true resilience. For occasion, in only one noteworthy initiative in Tehran through the 40-day wartime disaster in March, 15 complicated liver transplant surgical procedures have been efficiently carried out, IRNA quoted Jafarian as saying.
Iran is keen to broaden cooperation in completely different fields together with tuberculosis analysis, new vaccines, and superior diagnostics, he added.